Positive study results for Eisai-Biogen lifted the prospects for its medication and one from Eli Lilly—although regulators will have to weigh risks

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Australian Open bans flags from Russia, Belarus on site

Flags from Russia and Belarus were banned from the site of the…

Biden to direct $100 million to medical support network key to vaccine strategy

WASHINGTON — President Joe Biden plans to make the country’s biggest investment…

Green Steel Becomes a Hot Commodity for Auto Makers

BERLIN—Auto makers are racing to find cleaner steel to build their cars.…

The Elizabeth Holmes Trial Is a Wake-Up Call for Sexism in Tech

Elizabeth Holmes followed the Silicon Valley playbook to a T. She was…